MicroRNA-654-3p enhances cisplatin sensitivity by targeting QPRT and inhibiting the PI3K/AKT signaling pathway in ovarian cancer cells.
Exp Ther Med
; 20(2): 1467-1479, 2020 Aug.
Article
in En
| MEDLINE
| ID: mdl-32742380
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Diagnostic_studies
Language:
En
Journal:
Exp Ther Med
Year:
2020
Document type:
Article
Country of publication:
Greece